CT Brain biopsy and infusion
Glioma surgical resection
Radiation Therapy Planning
For information on enrollment, or to refer a patient:
Christy Chessman (Service coordinator)
530 754 0606
VMTH Hospital Reception
530 752 1393
Peter J. Dickinson, BVSc, PhD, DACVIM (Neurology)
School of Veterinary Medicine
For more information about
Toca 511 and Toca FC
Toca 511 is a nonlytic retroviral replicating vector that delivers a Cytosine Deaminase (CD) gene selectively to cancer cells. Toca FC is an extended-release tablet containing the antifungal drug, 5-FC (flucytosine). Toca FC is used in combination with Toca 511 because CD catalyzes the conversion of 5-FC, to the anti-cancer drug, 5-FU (5-fluorouracil).
Toca 511 is administered transcranially directly into the tumor following stereotactic biopsy. 3-6 weeks following Toca 511, surgical resection will be performed with the option for adjuvant radiation therapy.
The Toca 511 & Toca FC investigational study has been approved by:
How It Works
We will be happy to review imaging data, diagnostics or clinical history for potential cases.
Dogs enrolled in the study will have the following procedures financially covered in addition to
Toca 511 ($12,000-15,000)
For additional information in brain tumors Click